MLH1 (human mutL homolog 1)
2005-02-01 Enrico Domingo  , Simo Schwartz Jr   AffiliationOncologia Molecular i Envelliment, Centre dInvestigacions en Bioqumica i Biologia Molecular (CIBBIM) Hospital Universitari Vall dHebron Passeig Vall dHebron 119-129 Barcelona 08035, Catalonia, Spain
Identity
HGNC
LOCATION
3p22.2
LOCUSID
ALIAS
COCA2,FCC2,HNPCC,HNPCC2,MMRCS1,hMLH1
FUSION GENES
DNA/RNA

Diagram of the MLH1 gene. Exons are represented by boxes (in scale) transcribed and untranscribed sequences in blue and yellow, with exon numbers on top and number of base pairs at the bottom. Introns are represented by black bars (not in scale) and the number of base pairs indicated. The arrows show the ATG and the stop codons respectively.
Description
The MLH1 gene is composed of 19 exons spanning in a region of 57360 bp.
Transcription
The transcribed mRNA has 2524 bp
Proteins

Diagram of the MLH1 protein in scale. Numbers inside the blue boxes indicate the exon from which is translated each part of the protein. The three boxes inside represent the ATPase domain, the MutS homologs interaction domain and the PMS2/MLH3/PMS1 interaction domain; C: Carboxyl-terminal; N: Amino-terminal
Description
Localisation
Nuclear
Function
MLH1 has no known enzymatic activity. MLH1 forms a heterodimer with PMS2 known as MutLa, although it can also bind to PMS1 or MLH3. This heterodimeric complex binds to the heteroduplexes MutSa (composed of MSH2 and MSH6) or MutSb (composed of MSH2 and MSH3), which recognize DNA lesions. The heterodimer formed by MLH1 is responsible for the recruitment of the proteins needed for the excision and repair synthesis.
Homology
MLH1 is homologue to the bacterial MutL gene, specially in the N-terminal region, and MLH1 homologues are also present in eukaryotes (for example in Mus musculus, Drosophila melanogaster, Caenorhabditis elegans or Saccharomyces cerevisae)
Mutations
Germinal
There are over 300 MLH1 germline mutations described all along the gene that cause hereditary non-polyposis colorectal cancer (HNPCC, see below). This mutations are not present in any particular hotspot or zone of the gene and include either nucleotide substitutions (missense, nonsense or splicing errors) or insertions/deletions (gross or small). In most of these mutations the resulting protein is truncated. There are also founding mutations which account for a high proportion of the HNPCC tumours in some specific populations (for example there are two Finnish mutations that delete the exons 16 or 6). Some germline genetic changes have also been described in both exons and introns as non pathogenic.
Somatic
There are described some sporadic mismatch repair deficiency cases (sporadic MSI) with somatic MLH1 mutations, although most of them have MLH1 promoter hypermetilation.
Implicated in
Entity name
HNPCC (Hereditary Non Polyposis Colorectal Cancer)
Disease
Predisposition to develop cancer, preferentially colorectal, but also in endometrium, ovary, urinary tract, stomach, small bowel, biliary tract and brain.
Oncogenesis
MLH1 mutations in HNPCC account for about 25% of the total cases approximately. This mutations are inherited in one allele and later the other allele is lost by LOH. This leads to mismatch repair deficiency in this patients, which is the cause of the accumulation of mutations along the genome, causing microsatellite instability (MSI) and promoting tumorigenesis. It has been suggested that low levels of MSI characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis.
Entity name
MSI (MicroSatellite Instability)
Note
Tumours in which the molecular feature that leads to cancer is the lost of the mismatch repair (MMR) system.
Disease
This phenotype is present in 15% of colorectal, gastric and endometrial cancer, and with lower incidence in some other tissues.
Prognosis
MSI tumours have better prognosis than the MicroSatellite Stable (MSS).
Oncogenesis
Sporadic MSI cases are mostly due to a biallelic hypermetilation of the MLH1 promotor and therefore lack of MLH1 protein expression. Few sporadic cases and about 25% of the HNPCC are due to different mutations in MLH1. These mutations are germline in HNPCC.
Entity name
Muir-Torre syndrome
Disease
Coincidence of at least one sebaceous adenoma, epithelioma or carcinoma and one internal malignancy.
Oncogenesis
Inherited MLH1 mutations can cause Muir-Torre syndrome (although MSH2 mutations are more present).
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 15563510 | 2005 | Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis. | Alazzouzi H et al |
| 8751876 | 1996 | The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. | Bapat B et al |
| 8145827 | 1994 | Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. | Bronner CE et al |
| 7696368 | 1995 | Microsatellite instability in inherited and sporadic neoplasms. | Eshleman JR et al |
| 11900875 | 2002 | DNA mismatch repair defects: role in colorectal carcinogenesis. | Jacob S et al |
| 9892201 | 1999 | hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. | Leung SY et al |
| 11920679 | 2002 | DNA mismatch repair and mutation avoidance pathways. | Marti TM et al |
| 12419761 | 2002 | Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review. | Mitchell RJ et al |
| 9671741 | 1998 | Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. | Veigl ML et al |
Other Information
Locus ID:
NCBI: 4292
MIM: 120436
HGNC: 7127
Ensembl: ENSG00000076242
Variants:
dbSNP: 4292
ClinVar: 4292
TCGA: ENSG00000076242
COSMIC: MLH1
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA443761 | Colorectal Neoplasms, Hereditary Nonpolyposis | Disease | Literature, MultilinkAnnotation | associated | 23788249 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37838086 | 2024 | Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation. | 0 |
| 37919876 | 2024 | Rare single-nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome. | 1 |
| 38061582 | 2024 | MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome. | 2 |
| 38317368 | 2024 | [Characteristics and clinical analysis of MLH1 c.463dupC gene mutation in a Lynch syndrome family]. | 0 |
| 38477507 | 2024 | Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention. | 1 |
| 38840222 | 2024 | TDP43 interacts with MLH1 and MSH6 proteins in a DNA damage-inducible manner. | 0 |
| 38874740 | 2024 | Unmasking early colorectal cancer clues: in silico and in vitro investigation of downregulated IGF2, SOCS1, MLH1, and CACNA1G in SSA polyps. | 0 |
| 37838086 | 2024 | Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation. | 0 |
| 37919876 | 2024 | Rare single-nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome. | 1 |
| 38061582 | 2024 | MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome. | 2 |
| 38317368 | 2024 | [Characteristics and clinical analysis of MLH1 c.463dupC gene mutation in a Lynch syndrome family]. | 0 |
| 38477507 | 2024 | Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention. | 1 |
| 38840222 | 2024 | TDP43 interacts with MLH1 and MSH6 proteins in a DNA damage-inducible manner. | 0 |
| 38874740 | 2024 | Unmasking early colorectal cancer clues: in silico and in vitro investigation of downregulated IGF2, SOCS1, MLH1, and CACNA1G in SSA polyps. | 0 |
| 37147951 | 2023 | Association of MLH1-93G>A polymorphisms toward lung cancer susceptibility and its association with clinical outcome in North Indian patients treated with platinum-based chemotherapy. | 0 |
Citation
Enrico Domingo ; Simo Schwartz Jr
MLH1 (human mutL homolog 1)
Atlas Genet Cytogenet Oncol Haematol. 2005-02-01
Online version: http://atlasgeneticsoncology.org/gene/149/mlh1
